Sfoglia per Rivista
The long-term outcome of high-risk follicular lymphoma patients receiving intensive therapy with autograft as primary treatment : results from three consecutive prospective trials performed in Italy over the past 18 years
2009 C. Tarella, M. Ladetto, M. Ruella, R. Passera, A. Pileri, A.M. Gianni, P. Corradini
Long-term outcome of ric-allo SCT for myeloma
2007 V. Montefusco, F. Ciceri, J. Peccatori, L. Farina, A. Oliveri, K. Aprile Hoenstaufen, G. Lambertenghi Deliliers, A.M. Gianni, M. Bregni, P. Corradini
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
2006 V. Perfetti, S. Siena, G. Palladini, M. Bregni, M. Di Nicola, L. Obici, M. Magni, L. Brunetti, A.M. Gianni, G. Merlini
Low dose alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia
2011 G. Gritti, G. Reda, F. Maura, A. Piciocchi, L. Baldini, S. Molica, A. Neri, A. Cortelezzi
Low dose campath 1-H is highly effective and safe in advanced chronic CLL
2006 A. Cortelezzi, M.C. Pasquini, U. Gianelli, B. Sarina, C. Vener, G. Reda, F. Ripamonti, L. Nobili, G. Lambertenghi Deliliers
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report
2007 F. Radaelli, G. Reda, F. Ripamonti, A. Gardellini, C. Vener, G. Lambertenghi Deliliers
Low risk IgG Monoclonal Gammopathy of undetermined significance (MGUS) : proposal and validation of a prognostic scoring system
2007 F.G. Rossi, L. Marcheselli, D. Rossi, V. Callea, A. Guffanti, V. Federico, M. De Muro, A. Baraldi, P. Musto, A. Bacigalupo, G. Gaidano, M.T. Petrucci, M. Goldaniga, L. De Paoli, L. Baldini
Low vitamin B6 levels and the risk of recurrent venous thromboembolism
2007 G. Hron, R. Lombardi, S. Eichinger, A. Lecchi, P.A. Kyrle, M. Cattaneo
Low-dose ALEMTUZUMAB monotherapy in advanced chronic lymphocytic leukemia
2006 A. Cortelezzi, M.C. Pasquini, G. Reda, F. Ripamonti, B. Sarina, W. Barcellini, G. Lambertenghi Deliliers
LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIA
1987 A. MAIOLO, P. FOA, M. CORTELLARO, G. LAMBERTENGHIDELILIERS, A. COLANTONI, B. CESANA, G. CASTOLDI, M. CAZZOLA, M. GIORDANO, A. RICCARDI, E. POLLI
Low-dose subcutaneous alemtuzumab therapy for patients with refractory chronic lymphoblastic leukaemia (B-CLL)
2005 A. Cortelezzi, M.C. Pasquini, N.N. Fantini, V.R. Zilioli, M. Colombi, B. Sarina, F. Somalvico, G. LAMBERTENGHI DELILIERS
Low-dose subcutaneous campath (CAM) is highly effective and safe in advanced and chemotherapy-refractory B-CLL : results of a prospectic and multicenter phase II study
2007 A. Cortelezzi, M.C. Pasquini, W. Barcellini, P. Musto, U. Gianelli, G. Reda, G. Lambertenghi Deliliers
Lymphoproliferative disease and acquired C1 inhibitor deficiency
2007 R. Castelli, D.M. Lambertenghi Deliliers, L.C. Zingale, E.M. Pogliani, M. Cicardi
Lymphoproliferative Disease In Primary B-cell Immunodeficiency : Lymphoplasmocytoid Lymphoma Or Sjogrens Pseudo-lymphoma
1986 C. Montecucco, E.L. Cherieligniere, R. Rosso, A. Riccardi, R. Carnevale, R. Caporali, M. Gorini
Macrophage ferroportin is essential for stromal cell proliferation in wound healing
2019 S. Recalcati, E. Gammella, P. Buratti, A. Doni, A. Anselmo, M. Locati, G. Cairo
Maldi-tof MS profiling identifies ion signals differently expressed in prognostically defined subsets of binet stage a B-Cell chronic lymphocytic (CLL) recognized by biological markers
2010 F. Morabito, S. Bossio, G. Cutrona, M. Gentile, A. Made, S. Matis, V. Gigliotti, E. Lucia, E. Vigna, C. Mazzone, P. Servillo, A.G. Recchia, A. Neri, M. Ferrarini, A. Qualtieri
Maldi-Tof ms profiling identifies n-acetylated thymosin beta4 (T4) as down-regulated in B-cell chronic lymphocytic leukemia
2011 S. Bossio, G. Cutrona, M. Gentile, E. Vigna, E. Lucia, C. Mazzone, S. Matis, S. Franzese, L. De Stefano, V. Gigliotti, C. Tripodo, K. Todoerti, A.G. Recchia, A. Neri, M. Ferrarini, A. Qualtieri, F. Morabito
Maldi-tof MS profiling to examine the protein content in B-cell chronic lymphocytic leukemia
2009 S. Bossio, G. Cutrona, M. Gentile, E. Vigna, E. Lucia, C. Mazzone, E. Urso, S. Fabris, S. Cavalcanti, A. Neri, M. Ferrarini, A. Qualtieri, F. Morabito
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients : an italian multidisciplinary consensus statement
2015 C. Girmenia, C. Viscoli, A. Piciocchi, L. Cudillo, S. Botti, A. Errico, L. Sarmati, F. Ciceri, F. Locatelli, M. Giannella, M. Bassetti, C. Tascini, L. Lombardini, I. Majolino, C. Farina, F. Luzzaro, G.M. Rossolini, A. Rambaldi
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
2006 G. Barosi, A. Carella, M. Lazzarino, M. Marchetti, M. Martelli, A. Rambaldi, C. Tarella, U. Vitolo, P. Zinzani, S. Tura
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile